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Background: Porcine circovirus type 2 (PCV2) is the causal agent of postweaning multisystemic wasting syndrome
(PMWS), which has severely impacted the swine industry worldwide. PCV2 triggers a weak and atypical innate
immune response, but the key genes and mechanisms by which the virus interferes with host innate immunity
have not yet been elucidated. In this study, genes that control the response of primary porcine alveolar
macrophages (PAMs), the main target of PCV2, were profiled in vitro.
Results: PAMs were successfully infected by PCV2-WH strain, as evidenced quantitative real-time polymerase chain
reaction (qPCR) and immunofluorescence assay (IFA) results. Infection-related differential gene expression was
investigated using pig microarrays from the US Pig Genome Coordination Program and validated by real-time PCR
and enzyme-linked immunosorbent assay (ELISA). Microarray analysis at 24 and 48 hours post-infection (HPI)
revealed 266 and 175 unique genes, respectively, that were differentially expressed (false discovery rate <0.05;
fold-change >2). Only six genes were differentially expressed between 24 and 48 HPI. The up-regulated genes were
principally related to immune response, cytokine activity, locomotion, regulation of cell proliferation, apoptosis, cell
growth arrest, and antigen procession and presentation. The down-regulated genes were mainly involved in
terpenoid biosynthesis, carbohydrate metabolism, translation, proteasome degradation, signal transducer activity,
and ribosomal proteins, which were representative of the reduced vital activity of PCV2-infected cells.
Conclusions: PCV2 infection of PAMs causes up-regulation of genes related to inflammation, indicating that PCV2
may induce systematic inflammation. PCV2 persistently induced cytokines, mainly through the Toll-like receptor
(TLR) 1 and TLR9 pathways, which may promote high levels of cytokine secretion. PCV2 may prevent apoptosis in
PAMs by up-regulating SERPINB9 expression, possibly to lengthen the duration of PCV2 replication-permissive
conditions. The observed gene expression profile may provide insights into the underlying immunological response
and pathological changes that occur in pigs following PCV2 infection.Background
Porcine circovirus 2 (PCV2) is a small, non-enveloped,
single-stranded and closed-circular DNA virus that has
been identified as the primary cause of postweaning
multisystemic wasting syndrome (PMWS) in pigs. PMWS
primarily affects pigs between the ages of five and 18 weeks.
The clinical signs include progressive weight loss, jaundice,
wasting, and respiratory disease, accompanied by increased
mortality. The mortality rates of PMWS vary from 1-2%,* Correspondence: heqigai@yahoo.com
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reproduction in any medium, provided the orbut may reach up to 30% in complicated cases. PMWS
has become endemic in many swine-producing countries,
including China, Canada, the United States, Venezuela,
Australia, and the United Kingdom [1-3].
DNA microarray technology, in combination with bio-
informatics, has emerged as an efficient high-throughput
tool that offers great advantages in the study of the gen-
omic expression profiles of cells and host-microbe interac-
tions [4]. This technology provides the ability to determine
gene expression levels of thousands of different genes sim-
ultaneously. Indeed, high density gene arrays have already
revealed the status of host gene expression following infec-
tion by several viruses and bacteria, including influenza Ahis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Streptococcus suis [8], and Haemophilus parasuis [9].
The major target cells of PCV2 are the porcine mono-
cyte/macrophage lineage cells (MLCs) [10-13]. One type
of MLC, porcine alveolar macrophages (PAMs), are the
primary responders of the pulmonary innate immune
system and defend against various pathogens [14]. While
PAMs are known to be involved in PCV2 defense, the
underlying molecular mechanisms of PCV2 pathogen-
icity remain to be completely elucidated. Furthermore,
an immunosuppressive role has been characterized for
PCV2 in porcine circovirus diseases (PCVD) [15,16], but
little is known about the genes that are involved in this
process. The presence of granulomatous inflammation
and multinucleated giant cells in PMWS pigs [16] sug-
gests a significant role for secreted cytokines and other
immune-related signaling factors. Previous studies have
investigated the cytokine and chemokine gene expression
profile of PMWS by transcriptomic and genomic analyses.
For example, the cytokine mRNA expression profile in
lymph nodes of PMWS pigs was reported [17], as was the
global transcriptome profile of colostrums-deprived piglets
experimentally infected with PCV2 [18,19]. The genomic
expression profile in lymph nodes of lymphoid-depleted
PCV2-infected pigs was also reported [20]. However, these
results can not fully illustrate the pathogenesis of PCV2.
Therefore, the objective of the present study was to
analyze the PCV2-induced gene expression profiles in iso-
lated PAMs in vitro in order to reveal specific mechanisms
of the host innate immune response to PCV2. TheFigure 1 Immunofluorescence antibody staining for PCV2-infected PA
isothiocyanate) is seen in PCV2-infected PAMs. (A) Bright microscopy image o
PAMs at 24 HPI. (D) PCV2-infected PAMs at 48 HPI. (B-D) were stained with PCtemporal gene expression profiling using a two-channel
microarray carrying thousands of genes was carried out
with PAMs at 24 and 48 hours post-infection (HPI) to
discriminate PCV2-induced early and late changes in gene
expression.
Results
Confirmation of PCV2 infection in PAMs
Immunofluorescence assay (IFA) revealed green fluores-
cent cells in the infected PAMs, indicating that the PAMs
were successfully infected by PCV2 at 24 and 48 hours
after inoculation (Figure 1). There were no significant
differences in the levels of viral DNA or virus particles
between the two time points (mean viral loads: 5.67±0.35
log10 and 5.72±0.49 log10). Neither PCV2 particles nor
the PCV2 nucleotide signal were detected in the mock-
inoculated PAMs at any of the experimental time points.
Transcriptome analysis of the PAM response to
PCV2 infection
The concentrations of RNA ranged from 0.67 to 1.97
μg/μL. All RNA samples were considered to be of high
quality, based on RNA integrity number (RIN) values
(ranging from 8.0 to 9.4). The isolated mRNA samples
from 24 HPI and 48 HPI PAMs hybridized to 6345 and
5856 probe sets on the transcriptome microarray,
respectively corresponding to 34.25% and 31.65% of all
probe sets (Additional file 1: Table S1). After quantile
normalization and statistical analysis, 1277 transcripts
were identified (false discovery rate (FDR)-adjustedMs. Intracytoplasmic bright green fluorescence (fluorescein
f mock-inoculated PAMs. (B) Mock-inoculated PAMs. (C) PCV2-infected
V2 Cap protein-specific monoclonal antibody. Magnification: ×400.
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greater change in differential expression and a FDR of
5% were chosen to determine up-regulated and down-
regulated genes. According to these criteria, 266 and 175
genes were differentially expressed (DE) from baseline
at 24 HPI and 48 HPI (Additional file 2: Table S2 and
Additional file 3: Table S3). According to the corre-
sponding biological process Gene Ontology (GO) terms,
or potential biological processes reported in recent publica-
tions, the majority of these genes were related to Immune
Response, Inflammatory Response, Antigen Processing
and Presentation of Peptide or Polysaccharide Antigen via
MHC Class II, Anti-viral Immune response, Cell Motility,
and Negative Regulation of Apoptosis (Table 1). However,
the differential expression between 24 HPI and 48 HPI
reached the threshold of statistical significance for only six
of those genes (Additional file 4: Table S4 and Additional
file 5: Table S5). A total of 17 differentially expressed genes
were selected to validate the microarray results by quanti-
tative reverse transcription PCR (qRT-PCR) using the
primers in Table 2. The qRT-PCR results confirmed, in
general, the patterns of up-regulated and down-regulated
expression of the 17 genes that was indicated by the micro-
array analysis (Table 3).
Functional GO analysis of DE genes in PCV2-infected PAMs
The Ingenuity pathway analysis (IPA) program was used
to determine the relevance of PAM gene functionalities
and gene networks associated with PCV2 infection.
While 266 (24 HPI) and 175 (48 HPI) DE genes were
imputed into IPA, only 173 and 124 were characterized
with specific cellular functions.
The 173 DE genes from 24 HPI PAMs were placed
into 19 functional groups (Additional file 6: Table S6
and Additional file 7: Figure S8). The most frequently
represented category of gene functionality was Inflam-
matory Response (Cellular Movement, and Immune Cell
Trafficking) with 22 genes, followed by Cell-To-Cell
Signaling and Interaction, Cellular Growth and Prolifera-
tion, and Cellular Compromise.
The 124 DE genes from 48 HPI PAMs were placed
into 16 functional groups (Additional file 8: Table S7
and Additional file 9: Figure S9). The most frequently
represented category of gene functionality was also
Inflammatory Response with 25 genes, followed by Anti-
gen Presentation, Cellular Movement, Lipid Metabolism,
Cell Cycle, and Cellular Growth and Proliferation.
qRT-PCR validated DE genes in PCV2-infected PAMs
In order to validate the differential expression of some of
the DE genes identified by microarray, eleven up-regulated
genes and six down-regulated genes were selected for qRT-
PCR analysis. All the selected genes were successfully
amplified and the expression patterns corresponded tothose observed by microarray. Although the extent of fold-
change (FC) varied between the qRT-PCR and microarray
results (Table 3 and Figure 2), the differential expression
patterns were coincident, indicating the reliability of the
microarray analysis.
Toll-like receptors pathway analysis
Activation of the innate immune response is controlled in
large part by the TLR family of pattern-recognition recep-
tors (PRRs). A previous study showed that the DNA of
PCV2 could impair the plasmacytoid- and monocyte-
derived dendritic cells ability to induce interferon (IFN)-α
and TNF-α by interacting with TLR7 and TLR9 [23]. In the
current study, we verified the expression of TLR1, TLR2,
TLR3, TLR4, CD14, TLR5, TLR6, TLR8, and TLR9 (the
primers are listed in Table 2. Surprisingly, the two time
points examined showed significant differences in up-
regulation of TLR1 (2.29-fold vs. 4.89 fold), TLR4 cofactor
CD14 (2.35-fold vs. 2.71-fold) and TLR9 (4.66-fold vs. 2.24-
fold), and down-regulation of TLR8 (3.01-fold vs. 1.72-fold).
Profile of PAM secreted cytokines in response to
PCV2-infection
When compared with the supernatant of mock-inoculated
PAMs, PCV2-infected PAMs secreted significantly higher
levels of interleukin (IL)-8 (340.09 ± 53.64 vs 77.43 ±
13.15, by 4~6-fold; Figure 3D). Tumor necrosis factor-
alpha (TNFα) (228.13 ± 49.36 vs 77.12 ± 9.10) and IL-6
(1827.02 ± 157.32 vs 542.70 ± 137.05) levels were signifi-
cantly higher in supernatants of PCV2-inoculated PAMs at
24 HPI (2~3-fold vs. mock-inoculated PAMs; Figure 3B-C).
Interferon-gamma (IFNγ), however, appeared to be signifi-
cantly down-regulated (552.87 ± 83.25 vs 889.99 ± 141.03,
by 1.70-fold) at 24 HPI but significantly up-regulated
(1848.10 ± 190.19 vs 892.37 ± 89.66, by 2-fold) at 48 HPI
(vs. mock-inoculated; Figure 3A). The relative mRNA levels
of porcine IL-8, TNFα, IL-6, and IFNγ showed the same
DE trends as the secreted protein levels (Table 3).
Discussion
PCV2 is an important pathogen of swine that has effects
on both the pork industry and animal welfare. Despite
the high mortality rates and widespread incidence of this
pathogen, a definitive cure has not yet been found. An
effective vaccine was created by Merial in 2005 (Circovac®;
Merial, France) [24], and entered into widespread use in
2009. Despite the fact that the current vaccine strategy
can efficiently control PCV2 infection, immunization fail-
ures exist in the field, and the molecular mechanisms
underlying PMWS and porcine dermatitis and nephropa-
thy syndrome (PDNS) caused by PCV2 remain largely
unknown. The present study aimed to identify genes
involved in the immune response against PCV2 in pri-
mary alveolar macrophages. Furthermore, by generating
Table 1 Functional grouping of genes differentially expressed (≥2-fold and P < 0.05, n = 3) between PCV2-infected and mock-infected control
Functional classification Gene name Gene symbol 24 HPI FC Q-value, % (24hpi) 48 HPI FC Q-value, % (48hpi) GenBank ID
Immune response
rho GDP dissociation inhibitor beta ARHGDIB 2.16 0.41 1.21 13.11 NM_001009600
CMRF35-like molecule 1 CLM1 2.35 0.95 1.38 13.11 AY457047
cathepsin C CTSC 2.12 3.06 1.74 11.46 NM_001814
cathepsin S CTSS 0.5 1.09 0.77 19.25 M90696.1
Fc fragment of IgG low affinity II b receptor FCGR2B 3.47 0.54 1.85 8.49 NM_001033013
neutrophil cytosolic factor 4 NCF4 2.62 0 2.12 6.28 NM_000631
Humoral immune response
chemokine ligand 16 CCL16 3.85 4.64 3.24 4.93 NM_004590;
CD74 molecule CD74 3.94 0 3.43 0.58 NM_213774
complement factor D CFD 0.36 0.41 0.59 2.88 NM_001928
C-type lectin domain family 2, member B CLEC2B 2.83 1.62 2.10 1.09 NM_005127
Inflammatory response
chemokine ligand 3-like 3 CCL3L3 7.58 0 2.46 1.64 NM_001001437
chemokine Ligand 5 CCL5 1.53 14.04 2.25 2.44 AK312212
chemokine ligand 5 CXCL5 32.28 0 12.96 0 EU176356
chemokine ligand 7 CXCL7 2.75 0.95 3.57 1.97 NM_213862.1
interleukin-6 IL6 2.26 4.65 1.36 13.43 NM_214399.1
S100 calcium binding protein A1 S100A1 0.31 0.41 0.40 0.71 NM_006271
S100 calcium binding protein A12 S100A12 10.98 0 5.13 1.09 FJ263393.1
S100 calcium binding protein A8 S100A8 12.96 0 6.83 0 FJ263391.1
S100 calcium binding protein A9 S100A9 20.00 0 9.71 0 FJ263392.1
serum amyloid A1 SAA1 14.59 0.54 1.82 24.35 NM_199161
secreted phosphoprotein 1 SPP1 2.66 2.39 1.67 24.35 AK296035
tumor necrosis factor, alpha-induced protein 6 TNFAIP6 6.54 0 3.26 0.58 NM_001159607
Lipid biosynthesis
Lysophosphatidic acid acyltransferase, delta AGPAT4 2.34 0 1.48 0.58 NM_020133
lysophosphatidic acid acyltransferase, zeta AGPAT6 1.56 0.54 2.03 0 NM_178819
alkylglycerone phosphate synthase AGPS 2.41 0.95 1.46 32.28 NM_003659
farnesyl-diphosphate farnesyltransferase 1 FDFT1 0.77 14.04 0.45 1.82 AK297868
isopentenyl-diphosphate delta isomerase 1 IDI1 0.84 26.53 0.46 2.88 NM_004508
inositol-3-phosphate synthase 1 ISYNA1 2.12 0.54 1.65 1.44 NM_016368
stearoyl-CoA desaturase SCD 2.46 0.54 3.37 8.49 AB208982


















Table 1 Functional grouping of genes differentially expressed (≥2-fold and P < 0.05, n = 3) between PCV2-infected and mock-infected control (Continued)
Locomotion
CD97 molecule CD97 1.50 3.06 2.17 1.64 NM_001784
coronin, actin binding protein, 1A CORO1A 2.64 0.54 1.26 4.65 NM_007074
chemokine ligand 10 CXCL10 7.69 4.93 2.58 1.07 NM_001565
Kallmann syndrome 1 sequence KAL1 0.43 1.44 0.46 4.65 NM_000216
mitogen-activated protein kinase 1 MAP2K1 2.03 0 1.17 1.7 NM_002755
platelet factor 4 PF4 4.15 0 3.80 1.64 NM_002619
phosphatidic acid phosphatase type 2B PPAP2B 8.45 0.95 3.04 11.46 NM_003713
prostaglandin-endoperoxide synthase 2 PTGS2 5.75 0 5.41 0 NM_001784
Lyase activity
aldolase C, fructose-bisphosphate ALDOC 3.08 0 2.18 3.33 AK294157
carbonic anhydrase XIII CA13 0.41 0.82 0.40 0.71 NM_198584
enolase 1, (alpha) ENO1 2.24 0 1.80 4.94 AK298600
N-acetylneuraminate pyruvate lyase NPL 1.71 1.62 2.28 0 AK297017
serine dehydratase SDS 7.58 0 9.14 0 NM_006843
Antigen processing and presentation
Major histocompatibility complex, class II, DO alpha DOA 2.29 0 1.42 13.11 NM_002119.3
Major histocompatibility complex, class II, DO beta DOB 17.85 2.39 3.78 1.64 NM_002120.3
Major histocompatibility complex, class II, DQ alpha 1 DQA1 2.07 1.62 1.37 9.21 M33906.1
Major histocompatibility complex, class II, DQ beta 1 DQB1 2.47 0 2.14 11.46 M32577
Major histocompatibility complex, class II, DR alpha DRA 7.87 0 3.69 1.08 NM_001134339
Major histocompatibility complex, class II, DR beta 1 DRB1 5.83 0.95 2.17 1.17 AY770514.1
Signal transducer activity
guanine nucleotide binding protein (G protein), gamma 2 GNG2 1.94 0.41 2.26 0.42 NM_0530
regulator of G-protein signaling 1 RGS1 1.02 58.23 0.47 4.25 NM_002922
transforming growth factor, alpha TGFA 2.79 0 1.54 14.86 AK312899
wingless-type MMTV integration site family, member 6 WNT6 0.49 1.09 0.64 21.46 NM_006522
Antiviral immune response
chemokine ligand 8 CCL8 8.02 0 3.17 0 NM_214214.1
extracellular matrix protein 1 ECM1 2.01 0.54 2.89 0 CB477333
IFN-gamma IFNG 0.49 0.41 3.18 0 NM_213948.1
interleukin 18 IL18 2.58 0.95 5.84 19.25 NM_001562
ISG15 ubiquitin-like modifier ISG15 1.56 10.92 2.51 0 EU584557.1
interferon-stimulated gene 20 kDa protein ISG20 1.49 61.10 2.20 4.94 NM_002201


















Table 1 Functional grouping of genes differentially expressed (≥2-fold and P < 0.05, n = 3) between PCV2-infected and mock-infected control (Continued)
Apoptosis
BCL2/adenovirus E1B 19kDa interacting protein 3 BNIP3 3.69 0 2.61 2.88 U15174.1
CD14 molecule CD14 3.60 0 3.87 0 NM_001097445
immediate early response 3 IER3 5.46 0.41 2.21 1.64 NM_003897
lectin, galactoside-binding, soluble, 1 LGALS1 0.42 0.82 0.66 10.51 NM_002305
interleukin 1 alpha IL1A 21.31 0 8.47 0 NM_214029.1
interleukin 1, beta IL1B 18.69 0 10.33 2.88 M15330.1
serine/threonine kinase 17a STK17A 1.53 1.62 2 1.64 NM_00476
tumor necrosis factor receptor superfamily,
member 10d, decoy with truncated death domain
TNFRSF10D 2.26 0 2.21 61.11 NM_003840
tumor necrosis factor alpha TNFα 5.13 0.41 1.96 6.28 EU682384.1
Cell proliferation
Betacellulin BTC 2.26 0.95 1.78 1.97 NM_001729
epithelial membrane protein 1 EMP1 0.49 0.82 0.62 2.88 NM_001423
fatty acid binding protein 3, muscle and heart FABP3 1.88 0.95 2.57 3.09 NM_004102
fms-related tyrosine kinase 1 FLT1 1.91 1.78 2.49 0 NM_002019
interleukin 2 receptor, gamma IL2RG 1.39 6.28 2.06 1.07 NM_000206
interleukin 8 receptor, beta IL8RB 1.33 45.16 3.41 0 NM_001557
v-myc myelocytomatosis viral oncogene homolog MYC 0.75 14.04 0.29 0.71 NM_002467
pro-platelet basic protein PPBP 2.75 0.95 3.57 1.97 NM_002704
Note: The DE genes are presented with putative functions assigned by the GO term and manual annotation. Many genes with multiple functions were only listed in one category according to specific biology


















Table 2 Priers used for qRT-PCR validation and additional expression profiling
Gene Primer sequence, 5′-3′ Amplicon length, bp GenBank accession number
HPRT-1 a Forward: TCATTATGCCGAGGATTTGGA 90 DQ136030
Reverse: CTCTTTCATCACATCTCGAGCAA
GAPDH b Forward: TGCCAACGTGTCGGTTGT 120 NG_007073.2
Reverse: TGTCATCATATTTGGCAGGTTT
CD14 Forward: AGAGTTCAAAGAGTAGGGAA 86 NM_001097445.2
Reverse: AACGCTATCTGTCCTCAC
GPNMB Forward: CCCTCACGAGCACCCTTGT 91 NM_001098584
Reverse: AAGAAGCCAACGAAGACCAGGAT
ICAM1 Forward: GCAAGAAGATAGCCAACCA 106 NM_000201.2
Reverse: TGCCAGTTCCACCCGTTC
IFNγ Forward: AAAGATAACCAGCCCATTC 93 NM_213948.1
Reverse: GTCATTCAGTTTCCCAGA
IL6 Forward: CCTTCAGTCCAGTCGCCTTCTCC 97 NM_214399.1
Reverse: GCATCACCTTTGGCATCTTCTTCC
IL8 Forward: CACTGTGAAAATTCAGAAATCATTGTTA 105 NM_213867.1
Reverse: CTTCACAAATACCTGCACAACCTTC
ISG15 Forward: GGAGGGTAGGGAGGAGGGA 108 EU584557.1
Reverse: ATGGGCGTCACACAGGCT
S100A1 Forward: GGGAGAACAGTTGAGCAGATGGT 104 NM_006271.1
Reverse: GGAGGGAACAGCGGGATGAA
S100A12 c Forward: GGCATTATGACACCCTTATC 168 NM_001160272.1
Reverse: GTCACCAGGACCACGAAT
S100A4 Forward: GGGGAAAAGGACGGATGAAGC 96 XM_001929560
Reverse: GCAGGACAGGAAGACGCAGTA
S100A8 c Forward: GCGTAGATGGCGTGGTAA 155 FJ263391.1
Reverse: GCCCTGCATGTGCTTTGT
S100A9 c Forward: CCAGGATGTGGTTTATGGCTTTC 186 NM_001177906.1
Reverse: CGGACCAAATGTCGCAGA
TLR1 b Forward: TGCTGGATGCTAACGGATGTC 102 NM_001031775.1
Reverse: AAGTGGTTTCAATGTTGTTCAAAGTC
TLR2 b Forward: TCACTTGTCTAACTTATCATCCTCTTG 162 AB085935.1
Reverse: TCAGCGAAGGTGTCATTATTGC
TLR3 b Forward: AGTAAATGAATCACCCTGCCTAGCA 112 DQ647698.1
Reverse: GCCGTTGACAAAACACATAAGGACT
TLR4 b Forward: GCCATCGCTGCTAACATCATC 108 AY535422.1
Reverse: CTCATACTCAAAGATACACCATCGG
TLR5 Forward: CTCGCCCACCACATTA 156 FJ668383
Reverse: TGAGGGTCCCAAAGAGT
TLR6 b Forward: AACCTACTGTCATAAGCCTTCATTC 95 NM_213760.1
Reverse: GTCTACCACAAATTCACTTTCTTCAG
TLR8 b Forward: AAGACCACCACCAACTTAGCC 105 NM_214187.1
Reverse: GACCCTCAGATTCTCATCCATCC
TLR9 b Forward: CACGACAGCCGAATAGCAC 122 AY859728.1
Reverse: GGGAACAGGGAGCAGAGC
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Table 2 Priers used for qRT-PCR validation and additional expression profiling (Continued)
TNFα Forward: TGGTGGTGCCGACAGATGG 102 EU682384.1
Reverse: GGCTGATGGTGTGAGTGAGGAA
VCAM1 Forward: TCAGGGAGGACACAAAGAAGGG 135 NM_213891.1
Reverse: AAACGGCAAACACCATCCAAAGT
a from reference [21], b from reference [22], c from reference [9].
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PCV2 pathogenic process in the target host cells, we
hoped to gain insights into the underlying molecular
interactions and signaling pathways that may represent
novel targets of improved preventative and therapeutic
strategies.
Toll-like receptors
Toll-like receptors are essential sensors of microbial infec-
tion that are involved in the recognition of a variety of
microbial products [25-27]. To date, 13 TLRs have been
identified and characterized for their particular cognate
ligands and signaling cascades to trigger pathogen-targeted
immune responses [28]. For example, TLR7 recognizes
guanosine- and uridine-rich sequences derived from ssRNA
viruses [29], while TLR9 recognizes single-stranded DNA
(ssDNA) in endosomal compartments and signals to induce
the production of type 1 interferons (IFNs) and pro-
inflammatory cytokines and chemokines; PCV2 DNA
has been shown to modulate cytokine secretion thoroughTable 3 qRT-PCR validation of representative genes that are d
PCV2-infected PAMs



















All reactions were performed in triplicate. FC: fold-change.interaction with TLR9 [30]. In our study of the circular,
single-stranded DNA virus, PCV2, differential gene expres-
sion of TLRs was found. Specifically, PCV2 infection of
PAMs led to increased expression of TLR1, TLR4 cofactor
CD14, and TLR9. Monocytic CD14 signaling is usually
activated upon exposure to bacterial LPS, and this mole-
cule’s up-regulation may induce ineffective antibacterial
immunity. In addition, a similar mechanism has been
demonstrated in human monocytic cells upon exposure to
the severe acute respiratory syndrome (SARS) coronavirus
[31]. These receptors’ up-regulation may contribute to the
increased sensitivity of macrophages to other pathogens,
thereby augmenting the inflammation and host immune
response. Such an enhanced immune response may be
beneficial, but an over-stimulation of the innate response
could result in tissue damage. For example, the same
phenomenon was observed upon macrophage exposure to
tobacco smoke, wherein the expression of TLR3 was
increased and severe inflammation was observed after
treated with TLR3 ligand [32].ifferentially expressed between control and
48 HPI

















−7.54(0.001) −2.90 −4.83 (0.005)
Figure 2 Validation of microarray data by qRT-PCR analysis. Fold-changes of gene expression in the PAMs following PCV2 infection
compared with the control group are shown. The fold-changes were calculated by the formula of 2-ΔΔ Ct. Data is presented as mean ± SD of
triplicate reactions for each gene transcript.
Figure 3 Validation of microarray data by ELISA. PCV2-induced changes in secreted levels of IFNγ (A), TNFα (B), IL-6 (C) and IL-8 (D). The
protein levels in culture supernatants of mock-inoculated and PCV2-infected PAMs were measured by ELISA. Data are expressed as ng/L of three
independent experiments. * 0.01 <p <0.05 and ** p<0.01 for PCV2-infected vs. mock-inoculated groups for the corresponding HPI.
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MHC class II molecules play a central role in the initi-
ation of the immune response by binding and presenting
immunogenic peptides to CD4+ Th lymphocytes. How-
ever, only a few cell types express MHC class II mole-
cules, such as the antigen presenting cell types that
include macrophages, B lymphocytes, Langerhans cells,
and dendritic cells. The very complex and tight regula-
tion of MHC class II gene expression has direct implica-
tions for T lymphocyte activation. These molecules
include DOA, DOB, DQA1, DQB1, DRA, and DRB1,
and their molecule chaperone CD74; all of which were
up-regulated in PCV2-infected PAMs. This expression
pattern contradicts the host response observed for other
viruses, such as African swine fever virus (CSFV) [33],
classical swine fever virus [34] and influenza A virus
[35], and that was observed in follicles and PAMs of
PMWS piglets [36,37]. Increased expression of MHC
class II molecular have been shown to be correlated to
increased interferon production in pigs infection in-
fected with hog cholera virus [38]. IFN-γ up-regulation
have been shown after 48 HPI, its up-regulation could
benefit PCV2 replication [39]. The aberrant expression of
class II antigens could also compromise production of im-
munoregulatory cytokines, compromising immune func-
tion and perhaps favor viral persistence through escape
from immune recognition.
Apoptosis and growth arrest
Apoptosis is considered to be an important host mech-
anism that interrupts viral replication and eliminates
virus-infected cells. Viruses often kill infected cells by in-
ducing apoptosis rather than necrosis, but repress apop-
tosis to prolong the life of the cell and increase the yield
of progeny virions. SERPINB9, also called PI-9, belongs
to the large superfamily of serine proteinase inhibitors,
which bind to and inactivate serine proteinases, and acts
to protect against granzyme B-mediated apoptosis [40].
PCV2-infected PAMs were found to have enhanced
SERPINB9 expression, which may serve to prevent apop-
tosis and allow for longer-term replication and more
virion production. BNIP3, an apoptosis-inducing dimeric
mitochondrial protein [41], was also found to be increased
in PCV2-infected PAMs. It is possible that this factor may
represent the host’s counter response to PCV2, by which
host-induced apoptosis would act to limit the amount
of infected cells. It is also possible that these BNIP3
overexpressing cells represent a subset of PAMs that have
reached full capacity of virus load, in which the virus itself
may have manipulated the host gene expression to facili-
tate cell death and release of the virus progeny.
Actin alpha 2 (ACTA2) is a smooth muscle α-actin,
whose expression is transformation-sensitive to growth
signals in normal cells. Actively proliferating fibroblastsand smooth muscle cells have low levels of ACTA2, but
the inhibition of cell proliferation by density arrest or
treatment with antimitotic agents induces the smooth
muscle α-actin promoter [42]. Thus, the ACTA2 up-
regulation that was detected in PCV2-infected PAMs
may be the result of growth arrest induced by the virus
The same phenomenon was found in Rhabdomyosar-
coma cells after EV71 infection [43].
ENO1 is involved in the induction of cell death in
fibroblasts and has been implicated in tumorigenicity of
human breast carcinoma cells [44]. Its regulation of cell
growth is further suggested by the presence of functional
transcriptional repression domains [45]. PCV2-infected
PAMs showed enhanced ENO1 expression. It is possible
that up-regulation of this gene may enhance growth arrest
in PCV2-infected cells, thereby culminating in cell death.
Inflammatory response
Serum amyloid A 1 (SAA1) is a member of the SAA
family of apolipoproteins synthesized in response to cy-
tokines released by activated macrophages, which often
serve as clinical markers of acute and chronic inflamma-
tory diseases [46]. The pattern of increased SAA1
expression observed in PCV2-infected PAMs suggested
that PCV2 induced an acute inflammatory response at
the early time point (24 HPI) of infection. TNF-α and
IL-1β are acute-phase proinflammatory mediators that
promote inflammation and induce fever, tissue destruc-
tion, and, in some cases, shock and death [47]. Our
study showed that PCV2 could induce TNF-α and IL-1β
expression (Table 1) in PAMs at 24 HPI and 48 HPI.
These results are in good agreement with those from a
previous study of lymphoid tissues and peripheral blood
mononuclear cells (PBMCs) of PMWS pigs [17,48].
SAA1, TNF-α, and IL-1β up-regulation after PCV2
infection suggests the occurrence of systemic inflamma-
tion following PCV2 infection.
Lymphohistiocytic to granulomatous pneumonia is a
common histopathological finding in naturally-acquired
PMWS and experimentally-infected PCV2 pigs [49,50].
Chemokines, such as MCP-1/CCL-2, were found to be
up-regulated in the PCV2-infected PAMs. In a previous
study, MCP-1 was suggested to play an important role in
the pathogenesis of granulomatous inflammation in
PMWS-affected pigs [51-53]. The progressive granuloma-
tous inflammation has been speculated to be compromise
organ function and result in PMWS-associated fatalities
[54]. Furthermore, the MCP-1 cytokine is known to be an
important chemokine for the recruitment of monocytes
from the blood [55]. Thus, macrophage infiltration has
been suggested as an important feature of the pathogen-
esis and progression of PMWS [56].
Recruitment of inflammatory cells in injured tissue is
regulated by various cytokines and chemokines. PMWS-
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CCL-2, IL-1β, IL-8, and TNF-α mRNA in the lymphoid
tissues and PBMCs, suggesting that such cytokines and
chemokines may contribute to the development of granu-
lomatous lymphadenitis and recruitment of macrophages
or other inflammatory cells to the PCV2-infected tissues
[17,52,57]. The PCV2-infected PAMs in our study showed
up-regulation of MIP-1, CCL-2, IL-1β, IL-8 and TNF-α
mRNA expression. TNF-α is known to activate micro-
vascular endothelium and cause a pyrexic response [47].
Increased production of TNF-α may induce fever and
respiratory distress in PCV2-infected pigs [58,59]. IL-8 is a
chemoattractant for neutrophils and other polymorpho-
nuclear leukocytes (PMNs) that are produced following
acute infection [60]. Interaction of IL-8 and MCP-1/CCL-2
is also known to trigger tight adhesion of monocytes to
vascular endothelium under flow conditions [61]. The abil-
ity of PCV2 to induce IL-8 production in PAMs or PBMCs
has been previously reported [57,62,63]. Similar to IL-8,
the PAM-derived chemokine AMCF-II/CXCL5 [64] is able
to recruit PMNs to a lesion area [65]. Unlike the PMN-
derived chemoattractants discussed above, MCP-1 is a
powerful chemoattractant for monocytes and its activities
can be further enhanced by IL-8 [61]. It is reasonable to
speculate that the development of interstitial pneumonia in
pigs suffering from naturally-acquired PMWS or experi-
mental infection of PCV2 may result from the recruitment
of acute phase inflammatory cells and subsequent mono-
nuclear phagocytic cells from blood vessels to interalveolar
septa and alveolar spaces by up-regulated cytokines and
chemokines released from PCV2-containing PAMs.
Antiviral immune response
IFNγ is a Th1-specific cytokine produced by macrophages,
NK cells, and other cell types during the onset of viral in-
fection. It has a potent antiviral property that contributes
to the control of acute viral infections, and is an important
mediator of cellular responses. IFNγ mRNA was found to
be slightly down-regulated at the early stage of in vitro
PCV2 infection (24 HPI) of PAMs. This repressed expres-
sion may be indicative of suppressed Th1 responses,
which may facilitate viral persistence and delayed viral
clearance. At the late stage of in vitro infection (48 HPI),
however, the IFNγ expression level increased. Such an up-
regulation of expression may indicate a virus-modulated
mechanism to enhance infection and replication at the
late stage of PCV2 infection in vivo [39].
Conclusions
This is the first study to evaluate the gene expression
profile of PCV2-infected PAMs in vitro. Microarray ana-
lysis showed that expression of 266 and 175 PAM genes
was altered after 24 and 48 hours of PCV2 infection,
respectively. Among these, several genes related to theinflammatory response were up-regulated, suggesting that
PCV2 may induce systemic inflammation. Collectively,
this work established a comprehensive differential tran-
scription profile of early and late PCV2 infection in PAMs,
which revealed that PCV2 can induce persistent cytokine
production mainly through the TLR1 and TLR9 pathways.
Methods
Virus and cells
The PCV2-WH strain (GenBank accession number:
FJ870967) was isolated from pooled samples of spleen
and lymph nodes of a PMWS-affected pig. The virus
was amplified by passaging in PCV-free porcine kidney
(PK-15) cells and confirmed as PCV2 by nucleotide
sequence analysis and reactivity with PCV2 Cap protein-
specific monoclonal antibody [66]. The titer of the
PCV2 inoculum was 1.0×107 TCID50/mL, as determined
by titration in PCV-free PK-15 cells.
All animals’ tissue collection procedures were performed
according to protocols approved by the Hubei Province PR
China for Biological Studies Animal Care and Use Commit-
tee. Three 3-week-old Large White piglets were obtained
from a herd in Hubei province, which tested negative for
both PCV2 and porcine reproductive and respiratory syn-
drome virus (PRRSV), and were raised in controlled lab
conditions. For the first three days of containment, the pigs
were administered daily doses of enrofloxacin (1 mL of 5%
solution) and lincospectin/spectinomycin (1 mL of 5 or
10% solution) to eliminate any residual bacterial pathogens
[67]. Seven days later, the piglets were sacrificed. PAMs
were collected by bronchoalveolar lavage and frozen in
liquid nitrogen, as previously described [68]. Prior to use,
the cells were confirmed as negative for PCV1, PCV2,
parvovirus, pseudorabies virus (PRV), classical swine fever
virus (CSFV), and PRRSV variously by PCR and RT-PCR
[69,70]. The PAM phenotype was confirmed by flow
cytometric detection of the macrophage markers SWC3,
CD169, and SLAII [68].
RNA isolation and IFA
PAMs were thawed and cultured for 48 h before treatment,
as previously described [71,72]. One primary culture from
each animal was split into two for experimental analysis.
The first was infected with PCV2-WH from the 11th
passage at a multiplicity of infection (MOI) of 1. The
second was mock-inoculated with DMEM to serve as a
control. Virus uptake by the cells was determined by IFA
using a PCV2 Cap protein-specific monoclonal antibody
[66] and by quantitative real-time PCR (qPCR) [73]. Briefly,
DNA was extracted from the cells using the E.Z.N.A.™ Viral
DNA Kit (OMEGA, USA) according to the manufacturer’s
instructions. The amplification was performed in a 25 μL
reaction mixture containing 12.5 μL of 2× THUNDERBIRD
Probe qPCR Mix (TOYOBO, Japan), 9.45 μL sterile,
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AGGAGGGCGTTCTGACT-3'), 10 pmol of reverse prim-
er (5′-CGTTACCGCTGGAGAAGGAA-3′), 4 pmol of
TaqMan probe (5′-AATGGCATCTTCAACACCCGCCT
CT-3′), 0.05 μL of 50× ROX reference dye, and 2 μL of
the extracted DNA. The reaction was run in a real-time
thermocycler (7500 PCR System; Applied BioSystems Inc.)
with the following conditions: 1 cycle at 50°C for 2 min,
1 cycle at 95°C for 10 min, and 45 cycles at 95°C for 15 s
and 62°C for 60 s (real time).
At 24 HPI and 48 HPI, the cells were collected for
RNA extraction with the TRIzol reagent (Invitrogen Life
Technologies, USA). The extracted RNA was further puri-
fied with an RNA clean-up kit (Macherey-Nagel, Germany)
and applied to a Bioanalyzer 2100 spectrophotometer
(Agilent Technologies, USA) to assess the integrity, quality,
and quantity of the sample. The corresponding superna-
tants were collected for subsequent protein analysis and
stored at −80°C until use.
RNA labeling, microarray hybridization, and data analysis
RNA was converted to aminoallyl-RNA with the Amino
Allyl II MessageAmp™ aRNA Amplification Kit (Ambion,
USA) and labeled with either Cy3 or Cy5 (Reactuve Dye
Pack; Amersham, Sweden). Each Cy3- (or Cy5-) coupled
PAM sample was then hybridized to its corresponding
Cy5- (or Cy3-) coupled reference sample anchored on a
pig microarray slide containing 20,400 oligonucleotides
(US Pig Genome Coordination Program; http://www.
animalgenome.org/pig/resources/array_request.html).
Hybridizations and analyses were carried out according
to a previously published protocol from CapitalBio Cor-
poration (Beijing, China) [74]. Raw data was extracted from
the TIFF images using LuxScan 3.0 software (CapitalBio). A
spot-exclusion method was adopted to filter out faint spots,
with signal intensities in the lowest 50%, and exclude the
corresponding genes from further analysis. An intensity-
dependent LOWESS program in the R language package
was used to normalize the two-channel ratio values. As a
measure of technical replication, each experiment was
conducted with the corresponding dye swap.
Gene Cluster 3.0 and Eisen’s Treeview software (Stanford
University, USA) were used to compare similarities among
individual samples. Cy3/Cy5 ratios were log-transformed
(base 2), median centered by arrays and genes, and hier-
archically clustered (average linkage correlation metric). To
determine gene products with significantly up-regulated
expression, the PAM 24 HPI data sets were assessed for
increases in average intensity of at least 2-fold. Statistical
comparisons were performed by the one-class method in
the significance analysis of microarray (SAM software ver-
sion 3.0, Stanford University) [1]. All the microarray results
from this study were deposited in the NCBI Gene Expres-
sion Omnibus database under the following accessionnumbers: platform, GPL13968; Series, GSE30918; Samples,
GSM766444, GSM766445, GSM766446, GSM766447, GS
M766448, GSM766449.
Functional interpretation of microarray data as well as
pathway and network analysis
Differentially expressed genes were selected for pathway ex-
ploration using the IPA web-based query system (Ingenuity
Systems, www.ingenuity.com), this system can generate the
functional analysis and networks that are most significant
to the data set, IPA compares proteins in the input group
and displays a rank-ordered list of pathways and networks,
whose activities are most likely affected. Ficher’s exact test
was used to calculate a p-value determining the probability
that each biofunction assigned to that data set is due to
chance alone. Genes from the dataset that met the fold
change cut-off of 2.0 were considered for the analysis. The
score is the probability that a collection of proteins equal
to or greater than the number in a network could be
achieved by chance alone. A score of 3 indicates that there
is a 1/1000 chance that the focus proteins are in a network
due to random chance, therefore, score of 3 or higher have
a 99.9% confidence of not being generated by random
chance alone.
Quantitative RT-PCR
Equal amounts of RNA (1 μg) from PAMs was used to gen-
erate cDNA with oligo (dT) primers using the SuperScript
II RNase H Reverse Transcriptase Kit (Invitrogen, USA).
Quantitative RT-PCR reactions were set up in triplicate
using reagents from the SYBR Green I PCR Kit (Toyobo)
and 10 μM primers (designed by the Beacon Designer 7.0
program, www.premierbiosoft.com; Table 2). The amplifica-
tion reactions were performed on a LightCycler 480
(Roche) with the following conditions: 30 s at 95°C, 40
cycles of 95°C for 10 s, 60°C for 5 s and 72°C for 10 s.
Subsequently, melting curve analysis and quantitative
analysis of the data were performed using the Roche
LightCycler 480 software version 1.5.0. Each sample was
run in triplicate. Samples were normalized at each respec-
tive time point, using mock-infected PAMs as calibrators
and the hypoxantine phosphoribosyltransferase (HPRT-1)
and glyceraldehyde-3-phosphatedehydrogenase (GAPDH)
as the reference genes.. The average threshold cycles of the
replicates (each gene was detected three times) were used
to calculate the fold-changes between PCV2-infected or
mock-inoculated PAMs by using the formula of 2-delta-
delta Ct described by Livak and Schmittgen [75].
Cytokine detection in culture supernatant
The secreted protein levels of IFNγ, IL-6, IL-8 and TNFα
were determined by testing culture supernatants with
the respective commercial ELISA kits (R&D Systems,
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450 nm using an ELISA plate reader (Bio-Tek, USA).
Statistical analysis of quantitative PCR data
Statistical analyses were carried out using Microsoft Excel
2007 (Microsoft Co., USA). Differences between groups
were assessed by one-way repeated measures analysis of
variance followed by Tukey’s multiple comparison tests.
P-values less than 0.05 were considered to indicate
statistical significance.
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